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The prevalence of psychosis in epilepsy;
a systematic review and meta-analysis
Maurice J Clancy1,2†, Mary C Clarke1,3†, Dearbhla J Connor1, Mary Cannon1,2 and David R Cotter1,2*
Abstract
Background: Epilepsy has long been considered to be a risk factor for psychosis. However there is a lack of
consistency in findings across studies on the effect size of this risk which reflects methodological differences in
studies and changing diagnostic classifications within neurology and psychiatry. The aim of this study was to assess
the prevalence of psychosis in epilepsy and to estimate the risk of psychosis among individuals with epilepsy
compared with controls.
Methods: A systematic review and meta-analysis was conducted of all published literature pertaining to prevalence
rates of psychosis in epilepsy using electronic databases PUBMED, OVIDMEDLINE, PsychINFO and Embase from their
inception until September 2010 with the following search terms: prevalence, incidence, rate, rates, psychosis,
schizophrenia, schizophreniform illness, epilepsy, seizures, temporal lobe epilepsy.
Results: The literature search and search of reference lists yielded 215 papers. Of these, 58 (27%) had data relevant
to the review and 157 were excluded following a more detailed assessment. 10% of the included studies were
population based studies. The pooled odds ratio for risk of psychosis among people with epilepsy compared with
controls was 7.8. The pooled estimate of prevalence of psychosis in epilepsy was found to be 5.6% (95% CI: 4.8-6.4).
There was a high level of heterogeneity. The prevalence of psychosis in temporal lobe epilepsy was 7% (95% CI:
4.9-9.1). The prevalence of interictal psychosis in epilepsy was 5.2% (95% CI: 3.3-7.2). The prevalence of postictal
psychosis in epilepsy was 2% (95% CI: 1.2-2.8).
Conclusions: Our systematic review found that up to 6% of individuals with epilepsy have a co-morbid psychotic
illness and that patients have an almost eight fold increased risk of psychosis. The prevalence rate of psychosis is
higher in temporal lobe epilepsy (7%). We suggest that further investigation of this association could give clues to
the aetiology of psychosis.
Keywords: Psychosis, Epilepsy, Systematic review
Background
The nature of the relationship between psychosis and epi-
lepsy has been of great interest to psychiatrists for over a
century [1-12]. In one of the most epidemiologically
complete studies involving direct patient interviews of all
individuals with epilepsy in Iceland, Gudmundson (1966)
reported a rate of psychosis of 7.2% [13]. In keeping with
this the majority of studies [3,4,14,15] have found a higher
prevalence of psychosis in patients with epilepsy compared
with the general population, but this finding is not consist-
ent and reported rates varying from 0.48% [16] to 35.7%
[17]. Methodological differences such as changing diag-
nostic classifications, clinical heterogeneity, different as-
certainment methods, and lack of power likely account for
much of the inconsistency. Previous qualitative reviews of
this topic these reported an overall rate of psychosis in epi-
lepsy of 7% and 7.6% respectively [18,19]. More recently
Gaitatziz et al. looking at psychiatric morbidity overall in
epilepsy more recently, estimated that the prevalence of
psychosis in population based studies at between 2-7% and
estimated a prevalence of psychosis at 10-19% in patients
with TLE or refractory epilepsy [12].
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Improving our understanding of the basis to the rela-
tionship between psychosis and epilepsy is important as
it may provide clues to the pathophysiology of psychosis
generally [4,20,21]. In the current investigation we have
undertaken the first systematic review of the prevalence
of psychosis in epilepsy. Our main aim was to estimate
the overall pooled prevalence of psychosis among pa-
tients with epilepsy. Secondary aims were 1) to examine
the prevalence of psychosis associated specifically with
temporal lobe epilepsy, 2) to estimate the prevalence of
postictal and interictal psychosis, 3) to estimate preva-
lence of psychosis in specific subgroups of patients with
intellectual disability, children and adolescents, and indi-
viduals with genetic vulnerability to psychosis and 4) to
carry out separate analysis for studies with control
groups to allow estimation of risk for psychosis among
patients with epilepsy in terms of pooled odds ratios.
Methods
Study selection
We conducted a systematic review of all published lit-
erature in English on the prevalence of psychosis in pa-
tients with epilepsy. We were guided by PRISMA criteria
[22]. A search was undertaken of the electronic databases
PUBMED, OVID MEDLINE and EMBASE from their in-
ception to September 2010 with the following terms:
prevalence, incidence, rate, rates, psychosis, schizophrenia,
schizophreniform illness, epilepsy, seizures and temporal
lobe epilepsy. In addition to this search procedure, we
used the reference lists of the identified publications to
find further relevant articles.
Inclusion criteria
Papers were included if they gave prevalence rates of
psychosis, schizophrenia, interictal psychosis (see defin-
ition below) or postictal psychosis (see definition below)
in persons with epilepsy. We included studies involving
adults, children and patients with learning disability.
The definition of interictal psychosis (also known as
the schizophrenia-like psychosis in epilepsy) is a psych-
otic disorder that would fulfill diagnostic criteria for
schizophrenia if epilepsy was not present. The interictal
psychotic disorders are of reasonably long duration and
are not related to the occurrence of seizures [4,23].
The definition of postictal psychosis is a psychosis that
manifests itself immediately upon a seizure or emerges
with one week of return of apparently normal mental
function .The psychosis has to last a minimum length of
24 hours and a maximum length of 3 months [23].
Exclusion criteria
Papers excluded were those that (a) did not have the full
article published in English, (b) did not report preva-
lence rates or data from which rates could be calculated
(c) involved case reports, letters, short reports, reviews
or book chapters.
Data extraction
Following initial searches, all titles of papers and abstracts
were examined and assessed for relevance and appropri-
ateness of the main question under review. Full texts of
potentially relevant papers were obtained. Authors of pa-
pers were contacted where necessary. The methodological
quality of studies was assessed.
For the purpose of the meta-analysis, we extracted the
following domains or variables from the articles that
were finally included:
1) prevalence rates for psychosis including interictal and
postictal psychosis and schizophrenia. (where specified)
2) date of publication, country (developing or
developed world), year of publication, proportion of
children or individuals with learning disability within
epilepsy sample.
3) sample size, gender composition, whether the study
was carried out in a hospital or community setting,
study design (cross-sectional or cohort),
4) diagnosis of epilepsy and whether International League
Against Epilepsy (ILAE) classification was used
5) diagnostic tools used for psychosis and method of
obtaining diagnosis- (unstructured interview, case
note review, structured interview).
Data analysis
Pooled estimates of the prevalence of psychosis in epilepsy
patients were calculated using random-effects meta-
analysis. This allows a more robust and true estimate of
effect size and one that is weighted by the sample size of
individual studies. A random effects model weights studies
more equally and is considered more appropriate for meta-
analyses with substantial heterogeneity [24,25] and this
meta-analytic approach has been used with data containing
similar levels to those seen here [25]. The between-study
variance or heterogeneity in estimates was modelled using
Cochran Q and the I2 statistic. The Q statistic is reported
with χ2 and p-values and the I2 statistic is reported as a
percentage with increasing values indicating greater het-
erogeneity between estimates of individual studies (I2 <25%
indicates low heterogeneity; 30-70% =moderate heterogen-
eity and >75% indicates high heterogeneity [25]. Meta-
regression was used to estimate the extent to which
measured covariates (study design, study setting, assess-
ment instrument used, types of epilepsy, year of study,
family history of psychiatric illness, International League
Against Epilepsy (ILAE) classification used, exclusion cri-
teria applied, country in which study took place) could ex-
plain the observed heterogeneity in prevalence estimates
across studies. The regression coefficients (β) reported
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indicate the average difference in prevalence proportion for
one category compared to the other (eg assessment by clin-
ical interview versus case notes). Effects of individual co-
variates were examined first in univariate models and then
in a multivariate model constructed in a step-wise fashion.
All analyses were carried out using STATA statistical soft-
ware package, version 11.0.
Results
Literature search
Our preliminary search identified a total of 431 papers
on EMBASE, 773 papers on PUBMED and 999 papers
on MEDLINE via OVID. There was a substantial degree
of overlap between the 3 databases.
After these titles were screened, 215 papers were exam-
ined in detail. After applying inclusion and exclusion cri-
teria, 58 papers (27%) were deemed to have data relevant
to the systematic review and meta-analysis. See Figure 1.
Included studies and study design
Thirteen of the studies were from the UK, 11 from the
US, 11 from Japan, 5 from Brazil, 2 from Denmark, 2 from
the Netherlands, 2 from Canada, 2 from India,2 from
Iceland, 2 from Australia and 6 from other countries.
Ten papers specified the gender of participants in the
study. The number of patients with psychosis in the
studies varied from 1 [16,26-28] to 795 [29].
The number of participants in studies varied from 50
[30] to 34,494 [29]. With regard to the prevalence rates,
forty-eight studies were cross sectional studies, 9 were co-
hort and 1 was case control. The time periods over which
the prevalence rates were calculated were as follows: 27
studies were for an unknown time period, 7 studies were
lifetime prevalence studies, 21 studies were for more than
1 year and 3 studies were less than 1 year. Only 6 of the
studies had control groups [31-36].
Seven studies were in a community setting, 3 were in
a mixed hospital/community setting, 1 was unknown, 3
were from population databases and the remaining 44
were from hospital settings.
In 39 of the studies, patients were interviewed, in 19
studies the patients were not interviewed or it was not
stated in the study.
The prevalence rates of psychosis varied from 0.02%
[37] to 27% [17]. Forty of the studies used ICD criteria
or DSM criteria for diagnosis. Of these studies, 17 used
DSM IV criteria, 5 used DSM IIIR criteria, 1 used DSM
III criteria, 1 used DSM II criteria, 6 used ICD 10 cri-
teria, 4 used ICD 9 criteria and 1 used ICD 8 criteria. 5
studies used a mixture of these criteria.
Seven studies used a Structured Clinical Interview for
DSM IV on patients in their studies [26,31,38-42]. Nine
studies were conducted before 1990.
Seventeen of the 58 studies gave the prevalence of
schizophrenia. Ten studies had prevalence rates for inter-
ictal psychosis. Thirteen studies had prevalence rates for
postictal psychosis. Three studies used a sample group of
patients with children/adolescents only [14,27,43]. Four
studies studied patients with Learning Disability only
[32,44-46]. Seventeen studies included patients with TLE
only. Seven of the studies mentioned a family psychiatric
history, only 3 mentioned a family history of psychosis. 17
studies had TLE patients only, in 26 studies, the authors
did not differentiate whether patients had TLE or not and
in 15 studies, there was a mixture of patients with TLE
and other forms of epilepsy but unfortunately it was not
possible to extract the non TLE or TLE sample from each
other. Therefore for the TLE prevalence sample, we only
used studies where all the patients had TLE. We did not
contact authors personally to access data as this was not
possible in many of the studies as the contact details were
not current and 22 of the studies were conducted before
2000.
Prevalence of psychosis in epilepsy
Overall, the pooled prevalence rate for psychosis in epi-
lepsy patients was 5.6% (95% CI =4.8-6.4). (see Figure 2).
The pooled prevalence rate when postictal psychosis was
excluded was 5.4% (95% CI = 4.5-6.2).
The pooled prevalence rate for psychosis in patients
with temporal lobe epilepsy was 7.0% (CI 4.9-9.1). (See
Studies from 
electronic databases 
and reference lists
N=215
Excluded studies
N=157
Included articles
N=58
Review/commenta
ry/case reports 
N=82
Comparison study 
with other epilepsy 
types N=6
Papers not 
available in 
English N=25
No rates given 
N=30
Referred to same 
study N=2
Methodological 
problems N=12
Note-overlap 
reasons with 
some papers for 
excluded studies
Figure 1 PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta Analyses) flow diagram.
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Figure 3). The pooled prevalence rate of interictal psych-
osis was 5.2% (95% CI 3.2-7.2) and the pooled prevalence
rate for post ictal psychosis was 2.0% (95% CI 1.2-2.8).
Four papers studied an intellectual disability sample
only[32,44-46]. The prevalence of psychosis in patients
with epilepsy and comorbid learning disability was 7.4%
(95% CI 2.6-12.2).
Three studies used child and adolescent subjects only
[14,27,43]. The prevalence of psychosis in children and
adolescents with epilepsy was 5.4%, (95% CI 0.6-10.2).
Three papers mentioned a family history of psychosis.
The prevalence of psychosis in patients with epilepsy
where a family history of psychosis was present was
5.4% (95% CI = 1-9.8).
Six of the studies had control groups. However, only 4
studies [31,34-36] were used for analysis because two of
them [32,33] had no psychosis outcome in the control
group so an odds ratio could not be calculated. The
pooled odds ratio for risk of psychosis among people
with epilepsy was 7.83. (See Figure 4).
Heterogeneity analyses
There was substantial heterogeneity between the preva-
lence estimates of psychosis in epilepsy patients across in-
dividual studies (I2 > 70%). We examined the effect of
nine factors on the prevalence of psychotic symptoms in
epilepsy patients found across studies in a meta-regression
analysis: (1) study design (2) study setting (3) instrument
used to assess psychotic symptoms (4) types of epilepsy
(5) year of study (6) family history of psychosis noted (7)
ILAE classification used (8) exclusion criteria applied (9)
country in which the study took place.
Meta-regression analyses
None of the following factors significantly explained
any of the variance in the estimates on an individual
basis. (1) Study Design: (β = −1.1,SE(β = 1.9, p =0.58).
(2) Study setting: (whether recruiting patients from
the community or from hospitals or from tertiary cen-
tres) = (β -0.11, SE = (β) = 0.9, p =0.90). (3) Instrument
used to assess psychosis: (employing a clinical interview or
Figure 2 Pooled prevalence of psychosis in individuals with epilepsy.
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using case notes) (β = 0.31, SE(β) = 1.7, p =0.85). 4)
Types of epilepsy reported: (all types of epilepsy patients
or temporal lobe epilepsy patients only or other types of
epilepsy) = (β = 0.74, SE(β) = 0.8, p =0.39). 5) Year of
study: (whether studies carried out before 1990 or after
1990) (β = −2.8, SE (β) = 2.1, p =0.17). 6) Family history
of psychosis: family of history of psychosis assessed or
not assessed = (β = 3.7, SE(β) = 2.1, p =0.09).
7) ILAE classification used: studies reporting use of ILAE
classification or not reporting this classification = (β = 0.3 ,
SE (β) = 1.7, p =0.85). 8) Exclusion criteria applied: studies
reporting the use of exclusion criteria or those not
de Olivera (2010)
Jensen (1979)
Tebartz van Elst (2002)
Lindsay (1979)
McLellan (2005)
Shaw (2004)
Pritchard (1980)
Manchanda (1993)
Bladin (1992)
Guarnieri (2009)
Study Name
Christodoulou (2002)
Kanner (2009)
Kanemoto (2001)
de Araujo Filho (2007)
Oshima (2006)
Anhoury (2000)
Sherwin (1981)
(95% CI)
7.04 (4.95 9.14
5.50 (0.21, 10.79)
27.03 (16.91, 37.15)
4.60 (3.23, 5.97)
10.34 (3.95, 16.74)
1.67 (-1.57, 4.91)
3.44 (1.44, 5.43)
10.71 (2.61, 18.82)
1.34 (0.04, 2.65)
2.80 (-0.32, 5.93)
10.75 (6.30, 15.20)
1.06 (-0.13, 2.26)
4.00 (0.16, 7.84)
23.08 (11.63, 34.53)
23.58 (15.50, 31.67)
19.44 (11.98, 26.91)
Effect Size
2.75 (-0.32, 5.82)
11.11 (3.35, 18.87)
100.00
5.62
2.88
8.44
4.82
7.24
8.12
3.79
8.47
7.33
6.28
%
8.52
6.77
2.42
3.80
4.15
Weight
7.37
3.98
-37.1 0 37.1
Figure 3 Prevalence of psychosis in temporal lobe epilepsy.
Van der Feltz-Cornelius
Study Name
Stefansson (1998)
Mendez (1993)
7.83 (2.81, 21.79)
3.06 (0.31, 29.95)
33.53 (10.42, 107.88)
2.84 (1.28, 6.29)
9.50 (6.09, 14.81)
Effect Size
(95% CI)
100.00
12.87
24.34
29.36
33.42
Weight
.00927 1 108
%
de Araujo Filho (2007a)
Figure 4 Pooled odds ratio for studies with controls.
Clancy et al. BMC Psychiatry 2014, 14:75 Page 5 of 9
http://www.biomedcentral.com/1471-244X/14/75
reporting exclusion criteria (β = 1.1, SE(β) = 1.4, p =0.45). 9)
Country in which study took place: studies from countries
classified as ‘developed’ or those classified as ‘not devel-
oped’ (β = 2.0, SE(β) = 1.9, p =0.31).
A multivariate model constructed in step-wise fashion
showed that the specific combination of 5 factors ex-
plained the largest amount of heterogeneity in the preva-
lence estimates: Study setting; Assessment instrument
used; Year of study, Family history of psychosis; Type of
epilepsy. These 5 variables together explained 10% of the
variance in estimates of the prevalence of psychotic symp-
toms in epilepsy patients across studies.
Discussion
This is the first systematic review and meta-analysis to
examine the prevalence rate of psychosis in epilepsy. Our
finding of 5.6% pooled prevalence of psychosis in epilepsy
is lower than estimates of approximately 7% estimates
from previous narrative reviews, [18,19] although our find-
ing of 7% for the rate of psychosis in temporal lobe epi-
lepsy is similar. Based on results from population based
studies with control samples, [31,34-36] we found that the
rate of psychosis among people with epilepsy is 7.8 times
higher than in people without epilepsy. However there
were very few studies fulfilling these criteria. Our findings
are consistent with Gudmundsson who found that 7.2% of
subjects with epilepsy were currently or had at some time
suffered from psychotic illness [13].
We found a low prevalence of postictal psychosis in
epilepsy-2%. This has traditionally been described as the
most common form of psychosis in patients with epi-
lepsy [23]. Prevalence rates of around 6% from two tel-
emetry series have been reported in the past [39,47].
The relatively low postictal rate found in this study may
be explained by the transitory nature of PIP, it’s acute
and short presentation and that it is often managed in
non specialised departments and may go undiagnosed.
It may be mistaken for acute confusional states rather
than postictal psychosis. However, postictal psychosis
may be over or under represented depending on the
availability of psychiatric assessment, the frequency of
review and potentially the knowledge base of the treat-
ing neurologist and neuropsychiatry teams. The rate of
interictal psychosis at 5.2% was over two and a half
times the rate of postictal psychosis, but similar to the
rate for overall psychosis in epilepsy.
TLE is the most common of the anatomically defined
syndromes accounting for around 60% of all patients
with localisation related epilepsies [23]. It is the most
common type of epilepsy in adults who experience sei-
zures poorly controlled by anticonvulsant medication.
Our results found a slighter higher rate of psychosis in
TLE as compared to all epilepsies (7% v 5.6%). There
has been some debate in the past whether there is a
higher rate of schizophrenia-like-psychosis in patients
with TLE compared to generalized epilepsies. In the ori-
ginal study by Slater et al., the high rates of psychosis
may have been in part due to somewhat imprecise clin-
ical diagnostic data as the terms schizophrenia and
psychosis were relatively loosely defined by today’s stan-
dards [4]. There is also the possibility of an ascertain-
ment bias as the study drew its subjects from tertiary
centres in two major London hospitals. More recently,
Stevens argued that the proportion of TLE in epilepsy-
psychosis patients is similar to the proportion rate of gen-
eralized epilepsy patients with epilepsy psychosis which is
estimated to be about 60% [48-50]. Furthermore, in the
large epidemiological study by Qin et al., patients with
localization related epilepsy were only slightly over-
represented among those who were psychotic and this dif-
ference fell short of statistical significance [29]. Several
studies have failed to confirm the commonly held view
that there is a specific association between temporal lobe
epilepsy and psychopathology which is in contrast to com-
monly accepted clinical practice [51-53].
Methodological issues
Most of the studies included in this review were cross sec-
tional in design (77.6%) and based on samples from ter-
tiary referral centres (71%) and these factors may limit the
interpretation of the results with respect to the general
population. Only 10% of the studies were population-
based. Prevalence measures derived from such unrepre-
sentative samples may therefore overestimate psychiatric
morbidity among epilepsy patients [54].
We were unable to draw conclusions about the influ-
ence of a genetic vulnerability to psychosis from this study
as data was too limited. Family history of psychosis was
only mentioned in 3 studies [29,34,39]. Further family
studies are needed to elucidate this association. Hetero-
geneity may also play a role.
It was not possible to identify a group of patients which
did not have temporal lobe epilepsy to compare with the
TLE group as some studies did not state whether the pa-
tients had TLE or not and also some studies has TLE and
non TLE patients mixed together in their study samples,
thus it was impossible to differentiate these 2 disparate
groups out.
Temporality of the association between epilepsy
and psychosis
The question of whether epilepsy is a risk factor for psych-
osis and/or whether psychosis is a risk factor for epilepsy
has repeatedly arisen in the literature, however, very few
studies had the data necessary to adequately provide an-
swers [55]. We have not addressed the temporality of the
association in this study because the majority of studies in-
cluded do not have temporal information. However, Clarke
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et al. have recently found in a population based family
study that patients with epilepsy have a 5.5 fold increase in
the risk of having a broadly defined psychotic disorder and
an 8.5 fold increase in the risk of having schizophrenia
[56]. Individuals with a parental history of epilepsy had a 2
fold increase in the risk of developing psychosis, compared
to individuals without a parental history of epilepsy. Indi-
viduals with a parental history of psychosis had reciprocally
a 2.7 fold increase in the risk of having a diagnosis of gen-
eralised epilepsy compared to individuals without a paren-
tal history of psychosis. Post hoc analyses showed that
these analyses were not driven by the comorbidity of epi-
lepsy and psychosis in the parents.
Classification of psychosis
A consensus on the classification of psychotic symptoms
associated with epilepsy is lacking [57]. Neither ICD 10 nor
DSM Vclassify seizure-related psychosis separately. It could
be debated whether postictal psychosis for example should
be classified as a brief psychotic disorder/psychotic disorder
due to a general medical condition or a psychotic disorder
not otherwise specified in DSM. Furthermore, the psycho-
pathology of patients with epilepsy can be atypical and does
not readily conform to these diagnostic manuals [58].
A dedicated sub-commission of the International League
Against Epilepsy commission on neuropsychiatric aspects
has developed a proposal on the classification of neuro-
psychiatric disorders in epilepsy [59]. Recent genetic studies
reinforce the view that more attention should be given to
the relationship between the functional psychoses and neu-
rodevelopmental disorders such as autism [60].
Possible mechanisms
It has been suggested that the neurotoxic effect of epilepsy
explains the association between epilepsy and psychosis
[55]. Various mechanisms through which this effect might
be brought about have been proposed. These include
firstly, a ‘kindling’ process whereby acute seizure discharges
may cause changes in brain function perhaps through
receptor-based changes and changes in cerebral blood flow
[61]; secondly, a ‘forced normalisation’ process whereby an
inverse relationship exists between seizure control and
psychotic symptoms [57,62] and thirdly, on-going subictal
activity in the limbic system that is undetectable on EEG
but which leads to brain changes that result in psychosis
[55,63].
Antiepileptic medication may also play a role in the de-
velopment of psychosis especially among patients with
other risk factors such as family history or past psychiatric
history. Psychoses have been noted as a potential adverse
effect in many different antiepileptic medications suggest-
ing that the phenomenon is not medication specific. Anti-
epileptic medications implicated include ethosuxamide,
topiramate, vigabatrin, zonisamide and leviteracetam [64].
One study found a prevalence of psychosis of 3.7% in pa-
tients after they were commenced on topiramate [65].
High starting doses of medication and a rapid titration
schedule in more vulnerable patients with past psychiatric
history and with more severe epilepsy with high seizure
frequency were associated with greater risk.
However, it is also possible that epilepsy and psychotic
illness may represent different outcomes of a common
aetiological process. Neuropathological, neuroimaging and
genetics findings show that similar structural brain abnor-
malities and genetic abnormalities are present in patients
with schizophrenia and patients with epilepsy [55,66-71].
For instance, enlarged ventricles have been found to be
common to first episode psychosis and temporal lobe epi-
lepsy patients without psychosis [67]. Neuronal migration
defects have been proposed as a mechanism related to en-
larged ventricles and this defect could be common both to
schizophrenia and epilepsy. From a neurobiological per-
spective, significant grey and white matter deficits occur
in temporal lobe epilepsy with psychosis. Some of these
deficits overlap with those found in schizophrenia. These
include the medial temporal structures but also extend to
lateral temporal and extratemporal regions [70].
Recent genetic work shows that a rare genetic mutation
can lead to either epilepsy or schizophrenia. A micro-
deletion in the genomic area 15q 13–14 containing the
nicotine receptor was linked to development of either
schizophrenia or juvenile epilepsy [68,69,71]. The gene
leucine-rich glioma-inactivated 1 gene (LGI1) in autosomal
dominant partial epilepsy with auditory features, [72,73]
may also play a role in regulating glutaminergic synaptic
transmission, a process that is involved in the pathophysi-
ology of schizophrenia [74]. Genes encoding ion channels
may also be a source of interest. Ion channelopathies are
known to underlie some epilepsies and it has been shown
that variation within the gene CACNA1C (encoding a sub-
unit of the L-type voltage dependent calcium channel) is
associated with schizophrenia as well as depression and bi-
polar affective disorder [75]. This study provides support
for the possibility that some people might experience both
psychosis and epilepsy at least in part because of an under-
lying vulnerability to both.
Conclusions
In summary, adequate recognition and treatment of
psychosis in epilepsy is essential for patient management
because of their considerable burden in morbidity and
quality of life [12,76]. We would recommend that future
studies in this area should be used for defining psychotic
presentations. Improved diagnostic classification would
allow better characterisation of prevalence rates. Unfortu-
nately standardized criteria for psychiatric disorders such
as ICD 10 or DSM V do not allow this presently. Further
investigations in population-based studies are warranted
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for a more accurate prevalence rate at a population level
and family-based studies are needed to investigate the pos-
sible clustering of psychosis and epilepsy within families.
In conclusion, this study is the first meta-analysis and sys-
tematic review on the prevalence of psychosis in epilepsy.
The methodological rigour of a systematic review adds
clarity to the previous findings on this topic and confirms
the results. We report an almost 8-fold increased risk of
psychosis in epilepsy. An improved understanding of the
mechanisms underlying this association would be a fruitful
line of enquiry and may yield useful information on the
aetiopathogenesis of both psychosis and epilepsy.
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